Tazemetostat hydrobromide
CAS: 1467052-75-0
Ref. 3D-SIC05275
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Product Information
Tazemetostat hydrobromide is a potent and selective inhibitor of histone methyltransferase. This drug binds to the active site of the enzyme, preventing it from transferring methyl groups. Tazemetostat hydrobromide prevents the activation of cancer-related genes, which has been demonstrated in vitro using various cancer cell lines. Furthermore, this drug acts as an inhibitor of viral replication by inhibiting the production of new viruses. The polymorphic form of tazemetostat hydrobromide is found in human plasma and urine samples and may be used as a biomarker for cancer susceptibility. Tazemetostat hydrobromide may also be used as an antineoplastic agent against certain types of cancers due to its inhibition of histone methylation.
Chemical properties
Technical inquiry about: 3D-SIC05275 Tazemetostat hydrobromide
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.